Immunocore Holdings (IMCR) Receivables Refunds (2019 - 2025)
Immunocore Holdings (IMCR) has disclosed Receivables Refunds for 6 consecutive years, with $1.8 million as the latest value for Q4 2025.
- Quarterly Receivables Refunds changed N/A to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.8 million for FY2025, N/A changed from the prior year.
- Receivables Refunds hit $1.8 million in Q4 2025 for Immunocore Holdings, down from $3.5 million in the prior quarter.
- In the past five years, Receivables Refunds ranged from a high of $13.7 million in Q4 2022 to a low of $1.8 million in Q4 2025.
- Historically, Receivables Refunds has averaged $8.0 million across 4 years, with a median of $8.3 million in 2021.
- Biggest five-year swings in Receivables Refunds: increased 5.58% in 2022 and later tumbled 74.15% in 2023.
- Year by year, Receivables Refunds stood at $13.0 million in 2021, then rose by 5.58% to $13.7 million in 2022, then plummeted by 74.15% to $3.5 million in 2023, then plummeted by 48.79% to $1.8 million in 2025.
- Business Quant data shows Receivables Refunds for IMCR at $1.8 million in Q4 2025, $3.5 million in Q4 2023, and $13.7 million in Q4 2022.